Next Article in Journal
Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion Formulation
Next Article in Special Issue
Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?
Previous Article in Journal
Molecular and Nano-Structural Optimization of Nanoparticulate Mn2+-Hexarhenium Cluster Complexes for Optimal Balance of High T1- and T2-Weighted Contrast Ability with Low Hemoagglutination and Cytotoxicity
Previous Article in Special Issue
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(7), 1509; https://doi.org/10.3390/pharmaceutics14071509
Action Date Notes Link
article xml file uploaded 21 July 2022 08:22 CEST Original file -
article xml uploaded. 21 July 2022 08:22 CEST Update https://www.mdpi.com/1999-4923/14/7/1509/xml
article pdf uploaded. 21 July 2022 08:22 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1509/pdf
article supplementary file uploaded. 21 July 2022 08:22 CEST - https://www.mdpi.com/1999-4923/14/7/1509#supplementary
article html file updated 21 July 2022 08:23 CEST Original file -
article html file updated 13 August 2022 02:51 CEST Update https://www.mdpi.com/1999-4923/14/7/1509/html
Back to TopTop